Technical analysis of Charles River Laboratories International, Inc. (CRL): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific region.
Price Performance
| 1 month | +23.85% |
| 3 months | +55.68% |
| Year-to-date | +80.17% |
| 1 year | +99.59% |
| 3 years | +105.72% |
| 5 years | -16.79% |
| 10 years | +433.25% |
52-Week Range
| 52-week High | $379.63 |
| 52-week Low | $146.20 |
| Avg Volume (90d) | 993K |
Technical Indicators
| SMA 50 | $301.91 |
| SMA 200 | $221.78 |
| Beta | 1.62 |
| 30-day Volatility (annualised) | 46.6% |
| Price vs SMA 50 | +19.0% |
| Price vs SMA 200 | +62.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $199.48 | |
| 2026-01 | $210.48 | +5.5% |
| 2026-02 | $178.49 | -15.2% |
| 2026-03 | $172.50 | -3.4% |
| 2026-04 | $166.97 | -3.2% |
| 2026-05 | $180.71 | +8.2% |
| 2026-06 | $226.79 | +25.5% |
| 2026-07 | $232.51 | +2.5% |
| 2026-08 | $288.24 | +24.0% |
| 2026-09 | $295.01 | +2.3% |
| 2026-10 | $359.41 | +21.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-04 | $2.97 | $960M |
| 2026-08-05 | $2.74 | $977M |
| 2026-05-07 | $1.96 | $977M |
| 2026-02-18 | $2.33 | $987M |
| 2025-11-05 | $2.32 | $987M |
| 2025-08-06 | $2.50 | $969M |
| 2025-05-07 | $2.06 | $959M |
Price
| Price | $359.41 (closing price, October 30, 2026) |
| Market Cap | $17.3B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| Price / Book | 6.14 |
| EV / EBITDA | 91.38 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 1.07 |
| Current Ratio | 1.35 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 2.67 |